Supplement Claims Compliance 2026: U.S., EU, Middle East & Russia | HHC-Healthy

HHC Bio-Industry Co., Ltd. | Global Supplement Claims Compliance & OEM Production Insight

For dietary supplement brands expanding into international markets, product claims are more than a marketing issue. They can affect label review, packaging printing, product registration, and launch timelines. The same formula cannot automatically use the same claims across different countries.

In 2026, brands should coordinate target-market requirements, product formulations, claims, and label reviews before starting OEM production to reduce the risk of costly packaging changes and launch delays.

1. How Do Claim Requirements Differ Across Markets?

United States: Structure/function claims must be truthful, not misleading, and appropriately substantiated. Applicable FDA disclaimer and notification requirements must also be considered. Supplements must not be promoted as diagnosing, treating, curing, or preventing diseases.

European Union: Nutrition and health claims must be checked against applicable EU rules, authorized claims, and their conditions of use. Ingredient research alone does not automatically authorize a health claim on product packaging.

Middle East: Product classification, registration procedures, language requirements, and labeling rules can vary by country. Brands should confirm the requirements of each target market before finalizing packaging.

Russia: Brands should verify the applicable Eurasian Economic Union regulations, Russian-language labeling requirements, and relevant compliance documentation for their specific products.

2. Which Claim Risks Are Easy to Overlook?

Compliance risks can appear not only on the front label but also in product descriptions, advertisements, icons, and implied benefit statements.

For example, a brand may want to use wording such as “supports everyday wellness.” However, claims that imply disease treatment or lack adequate substantiation may create regulatory risks.

HHC-Healthy recommends confirming target markets, formula specifications, and proposed product claims before packaging design begins. Early coordination can help reduce the risk of label revisions after packaging materials have already been printed.

3. How Can Brands Reduce Risks Before OEM Production?

Before mass production, brands should confirm four key areas:

• Target markets: Identify the countries where the product will be sold and determine the applicable product classification.

• Formula review: Confirm ingredients, dosage levels, and product specifications.

• Claims review: Check claims used on packaging, labels, and marketing materials.

• Packaging approval: Finalize the correct label version before printing and production.

For OEM projects, HHC-Healthy can coordinate product specifications, formula adjustments, label information, quality control, and production documentation. This helps brands identify potential issues during production preparation. Final regulatory interpretations and claim approvals should be confirmed by the brand with appropriately qualified compliance professionals.

2026 Recommendations for Global Supplement Brands

Do not print packaging before confirming that the intended claims are suitable for the target market. Brands entering multiple countries should maintain market-specific label versions and review checklists, integrating compliance checks into their OEM production schedules.

HHC-Healthy specializes in OEM manufacturing of dietary supplements and herbal teas, supporting brands with customized product manufacturing, quality control, and packaging coordination.

📩 Facing a Similar Product or Labeling Challenge? Click “Contact Us” on the right.

📧 Email:lisa@hhc-healthy.com
🌐 Website:www.hhc-healthy.com